KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Sales (2019 - 2025)

Historic Return on Sales for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to 0.02%.

  • BioNTech SE's Return on Sales fell 1800.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.24% for FY2024, which is 6200.0% down from last year.
  • Latest data reveals that BioNTech SE reported Return on Sales of 0.02% as of Q3 2025, which was down 1800.0% from 1.61% recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Return on Sales peaked at 1.13% during Q4 2021, and registered a low of 6.25% during Q2 2024.
  • Over the past 5 years, BioNTech SE's median Return on Sales value was 0.53% (recorded in 2022), while the average stood at 0.24%.
  • Per our database at Business Quant, BioNTech SE's Return on Sales crashed by -51100bps in 2024 and then soared by 46400bps in 2025.
  • Quarter analysis of 5 years shows BioNTech SE's Return on Sales stood at 1.13% in 2021, then plummeted by -53bps to 0.53% in 2022, then increased by 10bps to 0.59% in 2023, then tumbled by -63bps to 0.22% in 2024, then plummeted by -109bps to 0.02% in 2025.
  • Its Return on Sales stands at 0.02% for Q3 2025, versus 1.61% for Q2 2025 and 2.6% for Q1 2025.